These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 33930716)
1. Elevated chemokines and cytokines for eosinophils in neuromyelitis optica spectrum disorders. Du L; Chang H; Xu W; Zhang X; Yin L Mult Scler Relat Disord; 2021 Jul; 52():102940. PubMed ID: 33930716 [TBL] [Abstract][Full Text] [Related]
2. Elevated Plasma Chemokines for Eosinophils in Neuromyelitis Optica Spectrum Disorders during Remission. Tong Y; Yang T; Wang J; Zhao T; Wang L; Kang Y; Cheng C; Fan Y Front Neurol; 2018; 9():44. PubMed ID: 29497397 [TBL] [Abstract][Full Text] [Related]
3. Cytokines and Tissue Damage Biomarkers in First-Onset Neuromyelitis Optica Spectrum Disorders: Significance of Interleukin-6. Wei Y; Chang H; Li X; Wang H; Du L; Zhou H; Xu W; Ma Y; Yin L; Zhang X Neuroimmunomodulation; 2018; 25(4):215-224. PubMed ID: 30544111 [TBL] [Abstract][Full Text] [Related]
5. Cytokine and Chemokine Profiles in Patients with Neuromyelitis Optica Spectrum Disorder. Wang Y; Zhou Y; Sun X; Lu T; Wei L; Fang L; Chen C; Huang Q; Hu X; Lu Z; Peng L; Qiu W Neuroimmunomodulation; 2016; 23(5-6):352-358. PubMed ID: 28445879 [TBL] [Abstract][Full Text] [Related]
6. CSF cytokine profile in MOG-IgG+ neurological disease is similar to AQP4-IgG+ NMOSD but distinct from MS: a cross-sectional study and potential therapeutic implications. Kaneko K; Sato DK; Nakashima I; Ogawa R; Akaishi T; Takai Y; Nishiyama S; Takahashi T; Misu T; Kuroda H; Tanaka S; Nomura K; Hashimoto Y; Callegaro D; Steinman L; Fujihara K; Aoki M J Neurol Neurosurg Psychiatry; 2018 Sep; 89(9):927-936. PubMed ID: 29875186 [TBL] [Abstract][Full Text] [Related]
7. Different roles of soluble CD40 ligand in central nervous system damage. Du L; Chang H; Wei Y; Zhang X; Yin L Neurol Res; 2020 May; 42(5):372-378. PubMed ID: 32178599 [No Abstract] [Full Text] [Related]
8. Interleukin-36 alpha levels are elevated in the serum and cerebrospinal fluid of patients with neuromyelitis optica spectrum disorder and correlate with disease activity. Song Y; Zhu M; Liu C; Zheng C; Zhou Y; Zhu J; Jin T Immunobiology; 2019 May; 224(3):397-401. PubMed ID: 30852049 [TBL] [Abstract][Full Text] [Related]
9. CSF-S100B Is a Potential Candidate Biomarker for Neuromyelitis Optica Spectrum Disorders. Wei Y; Chang H; Li X; Du L; Xu W; Cong H; Yao Y; Zhang X; Yin L Biomed Res Int; 2018; 2018():5381239. PubMed ID: 30426010 [TBL] [Abstract][Full Text] [Related]
10. Elevated cerebrospinal fluid β2-microglobulin levels in patients with neuromyelitis optica spectrum disorders. Zhang LJ; Qi Y; Liu MQ; Chang SH; Huang CN; Zhang QX; Wang N; Sun LS; Yang CS; Yang L Mult Scler Relat Disord; 2021 Apr; 49():102774. PubMed ID: 33713918 [TBL] [Abstract][Full Text] [Related]
11. Resolution of inflammation in neuromyelitis optica spectrum disorders. Wang X; Jiao W; Lin M; Lu C; Liu C; Wang Y; Ma D; Wang X; Yin P; Feng J; Zhu J; Zhu M Mult Scler Relat Disord; 2019 Jan; 27():34-41. PubMed ID: 30300851 [TBL] [Abstract][Full Text] [Related]
12. Clinical Features of Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders. Chen H; Liu SM; Zhang XX; Liu YO; Li SZ; Liu Z; Dong HQ Chin Med J (Engl); 2016 Sep; 129(17):2079-84. PubMed ID: 27569235 [TBL] [Abstract][Full Text] [Related]
13. Migration of eosinophils across endothelial cell monolayers: interactions among IL-5, endothelial-activating cytokines, and C-C chemokines. Shahabuddin S; Ponath P; Schleimer RP J Immunol; 2000 Apr; 164(7):3847-54. PubMed ID: 10725746 [TBL] [Abstract][Full Text] [Related]
14. Chitinase effects on immune cell response in neuromyelitis optica and multiple sclerosis. Correale J; Fiol M Mult Scler; 2011 May; 17(5):521-31. PubMed ID: 21159721 [TBL] [Abstract][Full Text] [Related]
15. Serum eosinophil cationic protein and 27 cytokines/chemokines in acute exacerbation of childhood asthma. Kato M; Yamada Y; Maruyama K; Hayashi Y Int Arch Allergy Immunol; 2010; 152 Suppl 1():62-6. PubMed ID: 20523065 [TBL] [Abstract][Full Text] [Related]
16. Correlation between serum levels of endothelin-1 and disease severity in patients with neuromyelitis optica spectrum disorders. Yi M; Liu MQ; Chou LS; Jiang SM; Zhang LJ; Huang CN; Wang N; Zhang QX; Yang L Immunobiology; 2020 May; 225(3):151959. PubMed ID: 32517881 [TBL] [Abstract][Full Text] [Related]
17. Activation of humoral immunity and eosinophils in neuromyelitis optica. Correale J; Fiol M Neurology; 2004 Dec; 63(12):2363-70. PubMed ID: 15623701 [TBL] [Abstract][Full Text] [Related]
19. NLRP3 level in cerebrospinal fluid of patients with neuromyelitis optica spectrum disorders: Increased levels and association with disease severity. Peng Y; Chen J; Dai Y; Jiang Y; Qiu W; Gu Y; Wang H Mult Scler Relat Disord; 2020 Apr; 39():101888. PubMed ID: 31869599 [TBL] [Abstract][Full Text] [Related]
20. Increased cerebrospinal fluid YKL-40 levels are associated with disease severity of neuromyelitis optica spectrum disorders. Qi Y; Chou LS; Zhang LJ; Liu MQ; Yi M; Zhang QX; Wang J; Li T; Zhang DQ; Yang L Mult Scler Relat Disord; 2020 Oct; 45():102395. PubMed ID: 32679524 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]